(Q33386324)
Statements
1 reference
Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma (English)
1 reference
Sven de Vos
1 reference
André Goy
1 reference
Shaker R Dakhil
1 reference
Mansoor N Saleh
1 reference
Peter McLaughlin
1 reference
Robert Belt
1 reference
Christopher R Flowers
1 reference
Mark Knapp
1 reference
Lowell Hart
1 reference
Dipti Patel-Donnelly
1 reference
Martha Glenn
1 reference
Stephanie A Gregory
1 reference
Charles Holladay
1 reference
Tracy Zhang
1 reference
Anthony L Boral
1 reference
21 September 2009
1 reference
1 reference
Identifiers
1 reference